HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
2.500
-0.380 (-13.19%)
At close: Jul 24, 2026, 4:00 PM EDT
2.480
-0.020 (-0.80%)
After-hours: Jul 24, 2026, 6:40 PM EDT
HCW Biologics Employees
HCW Biologics had 35 employees as of December 31, 2025. The number of employees decreased by 1 or -2.78% compared to the previous year.
Employees
35
Change (1Y)
-1
Growth (1Y)
-2.78%
Revenue / Employee
$188,348
Profits / Employee
-$517,652
Market Cap
2.98M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 35 | -1 | -2.78% |
| Dec 31, 2024 | 36 | -9 | -20.00% |
| Dec 31, 2023 | 45 | 1 | 2.27% |
| Dec 31, 2022 | 44 | 0 | - |
| Dec 31, 2021 | 44 | 4 | 10.00% |
| Mar 31, 2021 | 40 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Virax Biolabs Group | 26 |
| GeoVax Labs | 19 |
| Decoy Therapeutics | 11 |
| Artelo Biosciences | 7 |
| Galmed Pharmaceuticals | 6 |
| Creative Medical Technology Holdings | 4 |
| GRI Bio | 4 |
| SciSparc | 3 |
HCWB News
- 3 days ago - HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027 - GlobeNewsWire
- 26 days ago - HCW Biologics regains compliance with Nasdaq - TheFly
- 26 days ago - HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter - GlobeNewsWire
- 26 days ago - Hcw Biologics Inc trading halted, news pending - TheFly
- 4 weeks ago - HCW Biologics announces 1-for-6 reverse stock split - TheFly
- 4 weeks ago - HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026 - GlobeNewsWire
- 5 weeks ago - HCW Biologics Registration statement: Registration filing - Filings
- 5 weeks ago - HCW Biologics announces data from first two dose cohorts of HCW9302 trial - TheFly